PT Sarana Meditama Metropolitan Tbk (SAME.JK)
IDR 290.0
(-1.36%)
IDR 290.0
(-1.36%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 1535.63 Billion IDR | 10.2% |
| 2022 | 1393.54 Billion IDR | 9.59% |
| 2021 | 1271.58 Billion IDR | 150.5% |
| 2020 | 507.61 Billion IDR | -4.1% |
| 2019 | 529.31 Billion IDR | -44.4% |
| 2018 | 952.08 Billion IDR | 22.76% |
| 2017 | 775.56 Billion IDR | 22.13% |
| 2016 | 635.02 Billion IDR | 23.28% |
| 2015 | 515.09 Billion IDR | 24.29% |
| 2014 | 414.41 Billion IDR | 23.15% |
| 2013 | 336.51 Billion IDR | 24.42% |
| 2012 | 270.46 Billion IDR | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 411.89 Billion IDR | -5.48% |
| 2024 Q1 | 435.77 Billion IDR | 7.9% |
| 2024 Q3 | 433.64 Billion IDR | 5.28% |
| 2023 Q1 | 364.58 Billion IDR | -2.97% |
| 2023 Q4 | 403.87 Billion IDR | -1.26% |
| 2023 Q3 | 409.04 Billion IDR | 14.22% |
| 2023 Q2 | 358.12 Billion IDR | -1.77% |
| 2023 FY | 1535.63 Billion IDR | 10.2% |
| 2022 Q3 | 379.88 Billion IDR | 31.7% |
| 2022 Q4 | 375.73 Billion IDR | -1.09% |
| 2022 FY | 1393.54 Billion IDR | 9.59% |
| 2022 Q1 | 349.46 Billion IDR | 22.77% |
| 2022 Q2 | 288.45 Billion IDR | -17.46% |
| 2021 Q2 | 219.18 Billion IDR | 0.11% |
| 2021 Q3 | 548.81 Billion IDR | 150.39% |
| 2021 Q4 | 284.64 Billion IDR | -48.14% |
| 2021 FY | 1271.58 Billion IDR | 150.5% |
| 2021 Q1 | 218.93 Billion IDR | 33.1% |
| 2020 FY | 507.61 Billion IDR | -4.1% |
| 2020 Q1 | 136.62 Billion IDR | 2.48% |
| 2020 Q2 | 79.04 Billion IDR | -42.15% |
| 2020 Q3 | 127.45 Billion IDR | 61.25% |
| 2020 Q4 | 164.49 Billion IDR | 29.06% |
| 2019 Q1 | 274.94 Billion IDR | 6.29% |
| 2019 FY | 529.31 Billion IDR | -44.4% |
| 2019 Q4 | 133.32 Billion IDR | 205.58% |
| 2019 Q3 | -126.27 Billion IDR | -151.06% |
| 2019 Q2 | 247.33 Billion IDR | -10.04% |
| 2018 Q3 | 245.72 Billion IDR | 9.08% |
| 2018 FY | 952.08 Billion IDR | 22.76% |
| 2018 Q1 | 222.42 Billion IDR | 8.21% |
| 2018 Q2 | 225.25 Billion IDR | 1.28% |
| 2018 Q4 | 258.68 Billion IDR | 5.27% |
| 2017 FY | 775.56 Billion IDR | 22.13% |
| 2017 Q1 | 180.99 Billion IDR | 12.96% |
| 2017 Q2 | 188.65 Billion IDR | 4.24% |
| 2017 Q3 | 200.37 Billion IDR | 6.21% |
| 2017 Q4 | 205.54 Billion IDR | 2.58% |
| 2016 Q1 | 143.43 Billion IDR | 0.65% |
| 2016 FY | 635.02 Billion IDR | 23.28% |
| 2016 Q4 | 160.22 Billion IDR | -2.36% |
| 2016 Q3 | 164.09 Billion IDR | -1.89% |
| 2016 Q2 | 167.26 Billion IDR | 16.61% |
| 2015 Q2 | 129.94 Billion IDR | 12.13% |
| 2015 Q1 | 115.89 Billion IDR | 1.26% |
| 2015 FY | 515.09 Billion IDR | 24.29% |
| 2015 Q4 | 142.51 Billion IDR | 12.45% |
| 2015 Q3 | 126.73 Billion IDR | -2.47% |
| 2014 Q2 | 105.53 Billion IDR | 18.48% |
| 2014 FY | 414.41 Billion IDR | 23.15% |
| 2014 Q4 | 114.44 Billion IDR | 8.63% |
| 2014 Q1 | 89.07 Billion IDR | -0.34% |
| 2014 Q3 | 105.35 Billion IDR | -0.17% |
| 2013 Q1 | 73.17 Billion IDR | 1.85% |
| 2013 Q3 | 88.69 Billion IDR | 4.02% |
| 2013 Q4 | 89.38 Billion IDR | 0.78% |
| 2013 FY | 336.51 Billion IDR | 24.42% |
| 2013 Q2 | 85.26 Billion IDR | 16.52% |
| 2012 FY | 270.46 Billion IDR | 0.0% |
| 2012 Q4 | 71.84 Billion IDR | 5.56% |
| 2012 Q3 | 68.06 Billion IDR | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| PT Bundamedik Tbk | 1488.19 Billion IDR | -3.188% |
| PT Metro Healthcare Indonesia Tbk | 242.68 Billion IDR | -532.782% |
| PT Medikaloka Hermina Tbk | 5784.08 Billion IDR | 73.451% |
| PT Mitra Keluarga Karyasehat Tbk | 4264.27 Billion IDR | 63.988% |
| PT Murni Sadar Tbk | 921.91 Billion IDR | -66.571% |
| PT Famon Awal Bros Sedaya Tbk | 1839.23 Billion IDR | 16.507% |
| PT Royal Prima Tbk | 265.33 Billion IDR | -478.751% |
| PT Kedoya Adyaraya Tbk | 373.39 Billion IDR | -311.259% |
| PT Siloam International Hospitals Tbk | 11190.51 Billion IDR | 86.277% |
| PT Sejahteraraya Anugrahjaya Tbk | 2503.17 Billion IDR | 38.652% |